Clinical Trial Update: Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation [Phase 1]

View source ↗

Summary

Phase 1 safety study of multipotent progenitor cells for immunomodulation after liver transplantation was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Snippet

Sponsor: Prof. Dr. Marc-H. Dahlke, Ph. D. | Conditions: Liver Transplantation | Phase 1 | Status: TERMINATED | Results posted: 2018-08-17